You are here

 

IMPORTANT NOTICE:

Sometime before the end of the year, this website will be going full archive unless I can get support for maintaining the daily RSS feeds.  That means there will be no updating, although you will still be able to access the articles archived here.  Regardless, you also will no longer be able to deduct any donations you make because Vaccination News will no longer be a non-profit.  (Because I got so few donations in the past, we lost our “public charity” status some years ago and had to become a foundation, which costs much more to file with the IRS, and I am no longer willing to subsidize those costs.)

 

All the best,

Sandy Gottstein

President, Vaccination News

President, Vaccination News, A Non-Profit Corporation

Conflict of Interest Information - Drug Companies, CDC, FDA, Doctors,$$$$

xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns="http://www.w3.org/TR/REC-html40"> Conflict of Interest Information - Drug Companies, CDC, FDA, Doctors, $$$$

http://www.nccn.net/~wwithin/conflict.htm

 

Conflict of Interest Information - Drug Companies, CDC, FDA, Doctors, $$$$

Any information obtained here is not to be construed as medical or legal advice. The decision to vaccinate and how you implement that decision is yours and yours alone.


Congressman Burton critical of Vaccine Approval Process

Staff Report detailing conflicts of interest

US Congress Conflicts of Interest & Vaccine Development: Preserving the Integrity of the Process? - Hearings

Letters to Secretary Shalala

Info on Samuel Katz, MD who was featured on 60 minutes MMR/Autism Segment 11/12/2000
http://www.abcnews.go.com/sections/living/SecondOpinion/secondopinion_53.html
Also testifies AGAINST vaccine damaged children
Also one of the developers of measles vaccine and involved deeply with the vaccine industry
More conflict of interest links

Merck's Quiet Effort
Merck paid legislators, hospitals, docs and organizations!
4/16/200 Akron (Ohio) Beacon Journal
Merck's quiet effort
Vaccine maker backs legislation


Adm. William J. Crowe Jr. is the most visible corporate director of the Bioport Corp., which manufactures the anthrax vaccine. http://www.abcnews.go.com/onair/2020/2020_990312_anthrax_feature.html


War on Truth: The Secret Battle for the American Mind


"The fear is that the lure of profit could color scientific integrity, prompting researchers to withhold information about potentially dangerous side effects or push for experiments that might not be quite safe."


Proposed Research Misconduct Policy Discussed


Congress Explores Vaccine and Biological Weapons Links: Leading Expert Submits Stunning Suppressed NCI Reports


Rezulin Dangers Withheld
"The FDA is reviewing accusations that the manufacturer of the diabetes drug Rezulin withheld evidence of liver toxicity from the agency until six months after Rezulin was marketed. A spokeswoman for the agency said it would look into accusations by Public Citizen's Health Research Group, a patient advocacy group, that Rezulin's maker delayed telling the FDA that 21 patients had developed liver abnormalities while taking the drug before it was approved. Federal regulations require that drug companies report adverse drug reactions to the drug agency within 15 days of learning about them. In a March 14 letter to the agency, Public Citizen requested a criminal investigation of the manufacturer, Parke-Davis, division of the Warner-Lambert Company of Morris Plains, NJ"


Editorial Reply Re: Congressional Hearings on Vaccines and Autism

Mandating Vaccines: Government Practicing Medicine Without a License?

From: Dawn Richardson, PROVE

This is a phenomenal letter written by a parent of a vaccine injured child in response to an editorial comment published on WebMD. It clearly illustrates the incestuous ties some of those who make vaccine decisions for our children have with drug companies. These are the very people who are critical of the parents and elected representatives who are doing such a great job shedding light on some of the dangers of vaccines because of the threat the truth poses to their pocketbooks. The internet (source of all this information) is a wonderful thing.

----------------------------------------- In Reply to Editorial Comment from: Wayne L. Pines Re: Congressional Hearings on Vaccines and Autism

Wayne L. Pines, you belittle Congressman Burton as an "angry grandfather" when his goal is to make vaccines safer for children. Your feeble attempt to undermine Congressman Burton's efforts made sense only after your ties to the vaccine manufacturers and drug companies were revealed. This is a day in your life Wayne L. Pines. Let's see who you really are and then people will understand that your words are meaningless because they are motivated by avarice.

You started your career in Washington as the associate editor for The Pink Sheet a pharmaceutical trade magazine. Then you went to work at the FDA for 10 years from 1972 to 1982. Your next job was with the PR firm Burson-Marsteller. After that, you got a job with APCO Associates. Then you joined a company called Therametrix (1). In between you became involved with various pharmaceutical trade groups such as the Food and Drug Law Institute (2), the Drug Information Association (3), and the Internet Healthcare Coalition (4).

Now let's start connecting the dots to see why you would not want a public discussion about how to improve the safety of our children's vaccines. We'll pick-up your career after you leave the FDA. You immediately landed a job with the PR firm Burson-Marsteller (a subsidiary of the advertising agency Young & Rubicam). Your title there was executive vice president. Marsteller clients include Monsanto and their bio-engineered foods and Dow-Corning and their silicon breast implants. In addition, Marsteller has several large drug companies as clients including Eli Lilly. Lilly produces the drug Prozac which has accumulated more adverse reaction reports than any substance (besides vaccines) in the history of the FDA's adverse drug reporting system. Documents released under the Freedom of Information Act challenged the veracity of Prozac's clinical trials that led to FDA approval. Lilly's PR firm Burson-Marsteller was called in to do damage control. There, according to the Campaign Against Fraudulent Medical Research, it was reported that you helped Lilly get past its troubles by exploiting your contacts with current FDA officials (5).

You then became president of the Health Care Practice of APCO Associates a "communications consulting firm." According to PR Watch, APCO Associates specializes in setting up front groups and coalitions for the tobacco and insurance companies (6). In fact, APCO's website boasts that "excellence in public affairs and public relations, like excellence in art, is about the power of communication" (7). No it's not. Excellence in public affairs is about honest communication and adding substance to the public discourse. It's what Congressman Burton is doing. It's not about ridiculous, crude and poorly veiled attempts to protect and further your client base. You may think excellence in public affairs and public relations is about power, but power won't help you when it comes to our children. As much as it may disturb your plans, parents will not sacrifice the health and lives of their children in order to drive up the stock prices of your drug company clients.

Next you joined Therametrix whose website gloats that "Wayne L. Pines is a world-renowned health care consultant (who) has consulted for virtually all of the major pharmaceutical companies..."(1). It also states that Therametrix is a "medical marketing research agency that serves the pharmaceutical, biotechnology, medical device and consumer health products industries" (8). Your clients are listed as including: Abbot Laboratories, Bayer, Bristol-Myers Squibb, Du Pont Pharmaceuticals, Eli Lilly, Glaxo Wellcome, Novartis Pharmaceuticals, Pharacia & Upjohn, Procter & Gamble Pharmaceuticals, Roche Laboratories, Schering-Plough, Triangle Pharmaceuticals and Warner Lambert - all of them drug and vaccine manufacturers (9). Your company's mission statement declares, "We see nothing more important than meeting our client's needs" (9). I don't doubt it.

You are also on the marketing and advertising committee of the Drug Information Association which describes itself as a "member-driven scientific association with a membership of over 22,000 primarily from the regulatory agencies, academia, contract service organizations, pharmaceutical, biological and device industry, and from other health care organizations" (10). Who are some of the other committee members in the Drug Information Association? They include Dr. R. Venkataraghaven of Lederle Laboratories (3) manufacturer of Orimune, Tetramune and other vaccines, Dr. Elizabeth B. D'Angelo of AstraZeneca (3), and Dr. John F. Bedard of Bristol-Myers Squibb (3). The board of directors include Stuart W. Cummings of Merck, Sharp & Dohme manufacturer of the vaccines associated with autism - MMR, MR Vax, Meruvax II, Mumpsvax, Varivax and others, Francoise de Cremiers of Wyeth-Ayerst another major vaccine manufacturer, Charles C. Depew of SmithKline Beecham, Brenton James of Glaxo Wellcome, Murray Lumpkin of the FDA, and Irwin G. Martin of Parke-Davis (11).

In addition, you are a member of the Food and Drug Law Institute which describes itself "as a private organization, not affiliated with the FDA.(but our) mission, however, does relate to the activities, policies and procedures of the FDA..."(12). As a participant in this institute you work with the other members, and in fact, you are scheduled to moderate one of the institute's conferences on medical technology, drugs and biologics (i.e. vaccines) in June of this year (2). Nearly every drug company including the major vaccine manufacturers is a member of this organization. The list includes: American Home Products (i.e. Lederle), Bayer, Medeva Pharmaceuticals, Merck & Co., Organon Teknika, and SmithKline Beecham.

I could go on and on about your affiliations with vaccine manufacturers and drug companies but I believe the point has been made ad nauseam.

One of Congressman Burton's assertions is that an inherent conflict of interest may exist amongst the people who decide what gets injected into our children's veins. The Congressman understands that many of the individuals in our halls of government who make health decisions affecting our children get money from the very drug companies they are supposed to be regulating. During the hearings, when Coleen Boyle of the CDC was asked if she thought there was anything wrong with such a conflict she was literally speechless. Wayne L. Pines your behavior is a text book example of what Congressman Burton and tens of thousands of parents disdain.

As a former employee of the FDA you use your clout to influence what should be a scientifically sound, reasonable and objective decision making process. But even with all of your industry's money and consultants and PR firms and communication experts and doctors on payrolls you are still missing one key ingredient - the truth. The truth can't be bought, spun, manipulated, or turned into a sound bite. Parents know the truth when they watch their children become ill, disabled and die. So despite your supreme efforts to sell more vaccines, we will not allow some greedy industry to decide what is safe and to dictate to us what should be put into our children's bodies.

Wayne L. Pines go back to your "medical marketing research agency" and your "communications consulting firm," shut up, and leave our children alone.

Sincerely,

Michael Horwin Father of Alexander - a vaccine injured child who passed away at the age of 2 ½ years old

Footnotes:
1) http://www.therametrix.com/staff.html:
http://www.therametrix.com/wayne.html:
2) http://www.fdli.org/conf/medsymagd.htm:
3) http://www.diahome.org/dhp2d12.htm:
4) http://www.ihealthcoalition.org/content/fda_1.html:
5) http://www.pnc.com.au/~cafmr/newsl/prozac.html:
6) http://www.prwatch.org/prw_issues/1996-Q3/index.html:
7) http://www.apcoassoc.com/gallery/gallery.html:
8) http://www.therametrix.com/company.html:
9) http://www.therametrix.com/clients.html:
10) http://www.diahome.org/:
11) http://www.diahome.org/dhp2c.htm:
12) http://www.fdli.org/about/index.html:


CDC Funds Diversion Probed


CDC misled Congress on spending - Records show agency diverted funding, filed false reports

CDC caught devouring funds


Last Monday week, ABC TV had a story on Lateline about the control that the drug industry has taken of medical research.

Dr Marcia Angell, former editor of the New England Journal of Medicine, was interviewed. She says many significant things, but note this in particular as the core of it:

"It used to be that drug companies simply gave grants to academic medical centres for the use of their clinical researchers to do a study and that was it. It was at arm's length. The researcher did a study and he or she published the results, whatever those results would be. Now, it's very, very different. The drug companies increasingly design the studies. They keep the data. They don't even let the researchers see the data. They analyse the data. They decide whether they're going to even publish the data at the end of it. They sign contracts with researchers and with academic medical centres saying that they don't get to publish their work unless they get permission from the drug company. So, you can see that the distortion starts even before publication. It starts in determining what's going to be published and what isn't going to be published. This is no longer arm's length. It's treating the researchers and the academic medical centres as though they were hired guns or technicians or something. They just do the work. And the drug company will decide what the data show, what the conclusions are and whether it will even be published."


"Medical schools, professors, and drug companies are working hand-in-hand. The many financial ties between academic medicine and the pharmaceutical industry is raising questions and causing plenty of hand-wringing."


Policies About Physician Interactions With Drug Companies Needed


Critique of Government-Funded Epidemiology Harris Coulter


Medical Control, Medical Corruption


Financial Support to the Immunization Action Coalition
Deborah L. Wexler, MD
Executive Director
Immunization Action Coalition
**publisher of NEEDLE TIPS, VACCINATE ADULTS! and IAC EXPRESS**
1573 Selby Avenue, Suite 234
St. Paul, MN 55104
Phone: (651) 647-9009
Fax: (651) 647-9131
E-mail: deborah@immunize.org
http://www.immunize.org/
IAC EXPRESS: http://www.immunize.org/express/
-------------------------------------------------------------
Groups That Provide Financial Support to the Immunization Action Coalition in 1999

During 1999 the following groups provided funds to IAC: Government:
Centers for Disease Control and Prevention

Private Sources:
Approximately two thousand private individuals

Professional Organizations:
American Pharmaceutical Association

Corporations:
Chiron Corporation
GlaxoWellcome
Merck & Co.
Nabi
North American Vaccine
Pasteur Merieux Connaught
SmithKline Beecham
Wyeth Lederle Vaccines


The New England Journal of Medicine has a policy of disclosing authors' conflicts of interest, but sometimes the conflicts are too long to print! Here are the conflicts for just one article in the current issue where the authors are all academics.

http://www.nejm.org/content/2000/0342/0020/1462.asp

Supported by Bristol-Myers Squibb. Dr. Keller has served as a consultant to or received honorariums from Pfizer, Bristol-Myers Squibb, Forest Laboratories/Parke-Davis, Wyeth - Ayerst, Merck, Janssen, Eli Lilly, Organon, and Pharmacia - Upjohn. He has received research grants from Wyeth - Ayerst, SmithKline Beecham, Upjohn, Pfizer, Bristol-Myers Squibb, Merck, Forest Laboratories, Zeneca, and Organon. He has served on the advisory board of Wyeth - Ayerst, Pfizer, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories/Parke-Davis, Organon, SmithKline Beecham, Merck, Janssen, Mitsubishi Pharmaceuticals, Zeneca, Scirex, and Otsuka. Dr. Klein has served as a consultant to Bristol-Myers Squibb. Dr. Dunner has served as a consultant to Bristol-Myers Squibb, SmithKline Beecham, Glaxo Wellcome, and Eli Lilly. He has received research grants from Bristol-Myers Squibb, Pfizer, Pharmacia - Upjohn, SmithKline Beecham, Forest Laboratories, Glaxo Wellcome, and Wyeth - Ayerst. He has received speaker's honorariums from Bristol-Myers Squibb, SmithKline Beecham, Glaxo Wellcome, Eli Lilly, Organon, and Wyeth - Ayerst. Dr. Gelenberg has received grants and research support from Bristol-Myers Squibb, Organon, Pfizer, Lilly Research Laboratories, Janssen, Merck Sharp Dohme, SmithKline Beecham, Wyeth - Ayerst, Hoechst Marion Roussel, and Forest Laboratories. He has been a member of speakers' bureaus sponsored by Bristol-Myers Squibb, Pfizer, SmithKline Beecham, Janssen, Lilly, Forest Laboratories, and Parke-Davis. He is a stockholder or has other ownership interest in Pfizer, Warner-Lambert, and Eli Lilly. He has served as a consultant to Eli Lilly, Scios, Forest Laboratories, Parke-Davis, Pfizer, Janus Pharmaceuticals, Best Practice, and Bristol-Myers Squibb. Dr. Markowitz has received speaker's honorariums from Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Organon, and Pfizer. Dr. Nemeroff has been a consultant to or received honorariums from Abbott, AstraZeneca, Bristol-Myers Squibb, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi, Neurocrine Biosciences, Organon, Otsuka, Pfizer, Pharmacia - Upjohn, Sanofi, SmithKline Beecham, Solvay, and Wyeth - Ayerst. He has received research support from Abbott, AstraZeneca, Bristol-Myers Squibb, Forest Laboratories, Janssen, Eli Lilly, Organon, Pfizer, Pharmacia - Upjohn, SmithKline Beecham, Solvay, and Wyeth - Ayerst. Dr. Russell has been a consultant to or received honorariums from Abbott, Bristol-Myers Squibb, Janssen, Eli Lilly, Pfizer, and Quintiles. He has received research support from Abbott, Bristol-Myers Squibb, Eli Lilly, Parke-Davis, Pharmacia - Upjohn, Pfizer, SmithKline Beecham, Wyeth - Ayerst, Shire, and Quintiles. Dr. Thase has served as a consultant to Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Glaxo Wellcome/Cerenex Pharmaceuticals, Merck, Organon, Pfizer, Pharmacia - Upjohn, and Wyeth - Ayerst. He has received grant and research support from Bristol-Myers Squibb, Lipha Pharmaceuticals, Merck, Organon, Pharmacia - Upjohn, and Wyeth - Ayerst. He has been a member of speakers' bureaus sponsored by Bristol-Myers Squibb, Eli Lilly, Forest Pharmaceuticals, Glaxo Wellcome/Cerenex Pharmaceuticals, Organon, Parke-Davis, Pfizer, Pharmacia - Upjohn, SmithKline Beecham, Solvay, and Wyeth - Ayerst. Dr. Trivedi has received research grants from Abbott, Akzo (Organon), Bayer, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Glaxo Wellcome, Janssen, Johnson & Johnson, MeadJohnson, Parke-Davis, Pfizer, Pharmacia - Upjohn, Solvay, and Wyeth - Ayerst. He has been a member of speakers' bureaus sponsored by Bristol-Myers Squibb, Forest Laboratories, Pharmacia - Upjohn, Solvay, and Wyeth - Ayerst. Dr. Zajecka has received grants and research support from Abbott, Bristol-Myers Squibb, Eli Lilly, Glaxo Wellcome, Organon, Otsuka America, Parke-Davis, Pfizer, Pharmacia - Upjohn, and Sanofi Research. He has served as a consultant to or has served on the advisory board of Abbott, Bristol-Myers Squibb, and Eli Lilly. He has been a member of speakers' bureaus sponsored by Abbott, Bristol-Myers Squibb, Eli Lilly, Pfizer/Roerig, SmithKline Beecham, Upjohn, and Wyeth - Ayerst. Dr. Blalock has served as a consultant to Bristol-Myers Squibb. Dr. DeBattista has been a member of speakers' bureaus sponsored by Abbott, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Glaxo Wellcome, Parke-Davis, Pfizer, Scios, SmithKline Beecham, Wyeth - Ayerst, and Organon. He has received grants and research support from Abbott, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Glaxo Wellcome, Pfizer, the National Alliance for Research on Schizophrenia and Depression, Pharmacia - Upjohn, PharmaPrint/ABA, SmithKline Beecham, and Wyeth - Ayerst. He has served as a consultant to Bristol-Myers Squibb, Eli Lilly, Glaxo Wellcome, and PharmaPrint. Dr. Fawcett has received grants and research support from Abbott, Bristol-Myers Squibb, Glaxo, Eli Lilly, Organon, Pfizer, SmithKline Beecham, Wyeth - Ayerst, and Zeneca. He has served as a consultant to Abbott, Bristol-Myers Squibb, Eli Lilly, EM Industries, Forest Laboratories, Glaxo Wellcome, Pfizer, Pharmacia - Upjohn, and SmithKline Beecham. He has been a member of speakers' bureaus sponsored by Abbott, Bristol-Myers Squibb, Eli Lilly, Pfizer/Roerig, Pharmacia - Upjohn, SmithKline Beecham, and Wyeth - Ayerst. Dr. Hirschfeld has received grants and research support from Abbott, Bristol-Myers Squibb, Organon, and Pfizer. He has served as a consultant to or on the advisory board of Abbott, Bristol-Myers Squibb, Glaxo Wellcome, Forest Laboratories, Eli Lilly, Pfizer, SmithKline Beecham, Janssen, Organon, Parke-Davis, and Pharmacia - Upjohn. Dr. Kocsis has had research contracts with Bristol-Myers Squibb, Pfizer, Forest Laboratories, Eli Lilly, and Wyeth - Ayerst. He has received speaker's honorariums from Bristol-Myers Squibb, Forest Laboratories, and Eli Lilly. He owns stock in Pfizer and Forest Laboratories. Dr. Kornstein has received research grants from Bristol-Myers Squibb, Pfizer, Eli Lilly, Glaxo Wellcome, Forest Laboratories, Mitsubishi Pharmaceuticals, and Biovail. She has served as a consultant to Bristol-Myers Squibb, Pfizer, Eli Lilly, and Pharmacia - Upjohn. She has received honorariums from Bristol-Myers Squibb, Pfizer, and Glaxo Wellcome. Dr. Ninan has received grants and research support from Abbott, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Organon, Pharmacia - Upjohn, SmithKline Beecham, and Solvay. He has served as a consultant to Pfizer, TAPPharma, and Wyeth - Ayerst. He has been a member of speakers' bureaus sponsored by Abbott, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, Organon, Parke-Davis, Pfizer, Pharmacia - Upjohn, SmithKline Beecham, Solvay, Janssen, and Wyeth - Ayerst. Dr. Rothbaum has served as a consultant to Bristol-Myers Squibb and Pfizer. She has been a member of the advisory board of and a speakers' bureau sponsored by Pfizer. Dr. Rush has received grants and research support from Abbott, Bristol-Myers Squibb, Cyberonics, Eli Lilly, Forest Laboratories/Parke-Davis, Glaxo Wellcome, Janssen, Novartis, Organon, Pfizer, Pharmacia - Upjohn, SmithKline Beecham, Wyeth - Ayerst, and Zeneca. He has served as a consultant to Bristol-Myers Squibb, Cyberonics, Eli Lilly, Forest Laboratories/Parke-Davis, Glaxo Wellcome, Janssen, Merck, Organon, Pfizer, Pharmacia - Upjohn, and Wyeth - Ayerst. He has been a member of speakers' bureaus sponsored by Abbott, Bristol-Myers Squibb, Cyberonics, Eli Lilly, Forest Laboratories/Parke-Davis, Glaxo Wellcome, Organon, Pfizer, Pharmacia - Upjohn, and Wyeth - Ayerst. Dr. Schatzberg has served as a consultant to or received honorariums from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, Parke-Davis, Pfizer, Pharmacia - Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth - Ayerst. He has received research support from Bristol-Myers Squibb, Pfizer, and SmithKline Beecham. He has equity ownership in Corcept, Merck, Pfizer, and Scirex.

<CENTER

Medical Monopoly Information

The Medical Monopoly: Protecting Consumers or Limiting Competition? Sue A. Blevins

The Medical Monopoly: Your Tax Dollars Limit the Competition by Richard Leviton

Patient Power (How the Cost-Plus System Evolved)


Back to main Vaccine Dangers Page

 


Please call, write or email for more detailed information snakken@nccn.net

Back to Top


 ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.
 

 

 

Daily News Navigator